Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Correlation of Proton Pump Inhibitors with Pulmonary Tuberculosis: A Case-Control Study in Taiwan.

Cheng KC, Liao KF, Lin CL, Lai SW.

Front Pharmacol. 2017 Jul 19;8:481. doi: 10.3389/fphar.2017.00481. eCollection 2017.

2.

Acid-suppression medications and bacterial gastroenteritis: a population-based cohort study.

Wei L, Ratnayake L, Phillips G, McGuigan CC, Morant SV, Flynn RW, Mackenzie IS, MacDonald TM.

Br J Clin Pharmacol. 2017 Jun;83(6):1298-1308. doi: 10.1111/bcp.13205. Epub 2017 Jan 23.

3.

Use of Proton Pump Inhibitors and the Risk of Hospitalization for Infectious Gastroenteritis.

Chen Y, Liu B, Glass K, Du W, Banks E, Kirk M.

PLoS One. 2016 Dec 20;11(12):e0168618. doi: 10.1371/journal.pone.0168618. eCollection 2016.

4.

Proton pump inhibitors and gastroenteritis.

Hassing RJ, Verbon A, de Visser H, Hofman A, Stricker BH.

Eur J Epidemiol. 2016 Oct;31(10):1057-1063. Epub 2016 Mar 10.

5.

High incidence of hospitalisation due to infectious gastroenteritis in older people associated with poor self-rated health.

Chen Y, Liu BC, Glass K, Kirk MD.

BMJ Open. 2015 Dec 30;5(12):e010161. doi: 10.1136/bmjopen-2015-010161.

6.

PPI versus Histamine H2 Receptor Antagonists for Prevention of Upper Gastrointestinal Injury Associated with Low-Dose Aspirin: Systematic Review and Meta-analysis.

Mo C, Sun G, Wang YZ, Lu ML, Yang YS.

PLoS One. 2015 Jul 6;10(7):e0131558. doi: 10.1371/journal.pone.0131558. eCollection 2015.

7.

Raoultella planticola bacteremia following consumption of seafood.

Lam PW, Salit IE.

Can J Infect Dis Med Microbiol. 2014 Jul;25(4):e83-4.

8.

Association between recent use of proton pump inhibitors and nontyphoid salmonellosis: a nested case-control study.

Wu HH, Chen YT, Shih CJ, Lee YT, Kuo SC, Chen TL.

Clin Infect Dis. 2014 Dec 1;59(11):1554-8. doi: 10.1093/cid/ciu628. Epub 2014 Aug 4.

9.

Acid suppressive agents and risk of Mycobacterium tuberculosis: case-control study.

Hsu WH, Kuo CH, Wang SS, Lu CY, Liu CJ, Chuah SK, Kuo FC, Chen YH, Huang YB, Hou MF, Wu DC, Hu HM.

BMC Gastroenterol. 2014 May 13;14:91. doi: 10.1186/1471-230X-14-91.

10.

Diarrhea caused by proton pump inhibitor administration: comparisons among lansoprazole, rabeprazole, and omeprazole.

Shimura S, Hamamoto N, Yoshino N, Kushiyama Y, Fujishiro H, Komazawa Y, Furuta K, Ishihara S, Adachi K, Kinoshita Y.

Curr Ther Res Clin Exp. 2012 Jun;73(3):112-20. doi: 10.1016/j.curtheres.2012.03.002.

11.

Use of proton pump inhibitors after antireflux surgery: a nationwide register-based follow-up study.

Lødrup A, Pottegård A, Hallas J, Bytzer P.

Gut. 2014 Oct;63(10):1544-9. doi: 10.1136/gutjnl-2013-306532. Epub 2014 Jan 28.

12.

Managing peptic ulcer and gastroesophageal reflux disease in elderly Chinese patients--focus on esomeprazole.

Tang RS, Wu JC.

Clin Interv Aging. 2013;8:1433-43. doi: 10.2147/CIA.S41350. Epub 2013 Oct 25. Review.

13.

Use of proton pump inhibitors and subsequent risk of celiac disease.

Lebwohl B, Spechler SJ, Wang TC, Green PH, Ludvigsson JF.

Dig Liver Dis. 2014 Jan;46(1):36-40. doi: 10.1016/j.dld.2013.08.128. Epub 2013 Sep 12.

14.

Histamine H2 receptor antagonists for decreasing gastrointestinal harms in adults using acetylsalicylic acid: systematic review and meta-analysis.

Tricco AC, Alateeq A, Tashkandi M, Mamdani M, Al-Omran M, Straus SE.

Open Med. 2012 Aug 21;6(3):e109-17. Print 2012. Review.

15.

A patient on long-term proton pump inhibitors develops sudden seizures and encephalopathy: an unusual presentation of hypomagnesaemia.

Gandhi NY, Sharif WK, Chadha S, Shakher J.

Case Rep Gastrointest Med. 2012;2012:632721. doi: 10.1155/2012/632721. Epub 2012 Nov 18.

16.

Proton pump inhibitors are associated with a high rate of serious infections in veterans with decompensated cirrhosis.

Bajaj JS, Ratliff SM, Heuman DM, Lapane KL.

Aliment Pharmacol Ther. 2012 Nov;36(9):866-74.

17.

Campylobacter epidemiology: a descriptive study reviewing 1 million cases in England and Wales between 1989 and 2011.

Nichols GL, Richardson JF, Sheppard SK, Lane C, Sarran C.

BMJ Open. 2012 Jul 12;2(4). pii: e001179. doi: 10.1136/bmjopen-2012-001179. Print 2012.

18.

Transoral incisionless fundoplication for treatment of gastroesophageal reflux disease in clinical practice.

Witteman BP, Strijkers R, de Vries E, Toemen L, Conchillo JM, Hameeteman W, Dagnelie PC, Koek GH, Bouvy ND.

Surg Endosc. 2012 Nov;26(11):3307-15. doi: 10.1007/s00464-012-2324-2. Epub 2012 May 31.

19.

Acid peptic diseases: pharmacological approach to treatment.

Mejia A, Kraft WK.

Expert Rev Clin Pharmacol. 2009 May;2(3):295-314.

20.

The safety of drugs used in acid-related disorders and functional gastrointestinal disorders.

Parikh N, Howden CW.

Gastroenterol Clin North Am. 2010 Sep;39(3):529-42. doi: 10.1016/j.gtc.2010.08.009. Review.

Supplemental Content

Support Center